Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia.
Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
J Am Geriatr Soc. 2018 Jul;66(6):1180-1185. doi: 10.1111/jgs.15292. Epub 2018 Feb 12.
To detail annual trends in benzodiazepine incidence and prevalence in older adults between 2010 and 2016 in three countries.
Observational multicountry cohort study with harmonized study protocol.
The United States (veteran population); Ontario, Canada; and Australia.
All people aged 65 and older (8,270,000 people).
Annual incidence and prevalence of benzodiazepine use stratified according to age group (65-74, 75-84, ≥85) and sex. We performed multiple regression analyses to assess whether rates of incident and prevalent use changed significantly over time.
Over the study period, we observed a significant decrease in incident benzodiazepine use in the United States (2.6% to 1.7%) and Ontario (6.0% to 4.4%) but not Australia (7.0% to 6.7%). We found significant declines in prevalent use in all countries (United States: 9.2% to 7.3%; Ontario: 18.2% to 13.4%; Australia: 20.2% to 16.8%). Although incidence and prevalence increased with age in Ontario and Australia, they decreased with age in the United States. Incidence and prevalence were higher in women in all countries.
Consistent with other international studies, there have been small but significant reductions in the incidence and prevalence of benzodiazepine use in older adults in all three countries, with the exception of incidence in Australia, although use remains inappropriately high-particularly in those aged 85 and older-which warrants further attention from clinicians and policy-makers.
详细描述 2010 年至 2016 年期间,三个国家中 65 岁以上老年人苯二氮䓬类药物的发病率和患病率的年度趋势。
观察性多国队列研究,使用协调一致的研究方案。
美国(退伍军人人群);安大略省,加拿大;和澳大利亚。
所有 65 岁及以上人群(8270 万人)。
根据年龄组(65-74 岁、75-84 岁、≥85 岁)和性别分层,苯二氮䓬类药物使用的年度发病率和患病率。我们进行了多项回归分析,以评估新发病例和现患病例的使用率是否随时间显著变化。
在研究期间,我们观察到美国(从 2.6%降至 1.7%)和安大略省(从 6.0%降至 4.4%)苯二氮䓬类药物的新发病例使用显著减少,但澳大利亚(从 7.0%降至 6.7%)则没有。我们发现所有国家的现患病例使用都显著下降(美国:从 9.2%降至 7.3%;安大略省:从 18.2%降至 13.4%;澳大利亚:从 20.2%降至 16.8%)。尽管安大略省和澳大利亚的发病率和患病率随年龄增长而增加,但在美国则随年龄增长而降低。在所有国家,女性的发病率和患病率都较高。
与其他国际研究一致,除澳大利亚外,所有三个国家的老年人群中,苯二氮䓬类药物的发病率和患病率均出现了较小但显著的下降,尽管使用率仍然过高,尤其是在 85 岁及以上人群中,这值得临床医生和政策制定者进一步关注。